Opko Health Inc (OPK) Company Profile & Statistics

Opko Health Inc
OPK
(Nasdaq - US)
Closed
1.46
-0.02 (-1.35%)
in:usd•As of: Nov 05, 2024 15:59 UTC -5
Open
1.47
High
1.47
Low
1.43

About Opko Health Inc

CEO

Phillip Frost

Headquarters

4400 biscayne blvd.

miami, fl 33137, united states

Auditor

Ernst & Young LLP

Employees

3,930

Share Holders

368

Website

www.opko.com

Industry

medical or nursing services

Sector

health services

Company Overview

OPKO Health, Inc engages in the diagnostics and pharmaceuticals business in the United States, Ireland, Chile, Spain, Israel and Mexico. The Diagnostics segment operates Bio-Reference Laboratories, a clinical facility that offers testing services in the detection, diagnosis, evaluation, monitoring and treatment of diseases. The company's pharmaceutical business features Rayaldee, an FDA-approved treatment for secondary hyperparathyroidism (SHPT) in adults with stage 3 or 4 chronic kidney disease (CKD) and vitamin D insufficiency and VARUBI for chemotherapy induced nausea and vomiting. OPKO Health has a development and commercial supply pharmaceutical unit in Ireland along with a global supply chain operation and holding wing. The company also owns specialty active pharmaceutical ingredients (APIs) manufacturer in Israel.

Opko Health Inc Statistics

Valuation Measures

Market Capitalization ²	1.02B
Enterprise Value	1.18B
Enterprise Value/EBITDA (ttm)	-7.22
Price to Earnings Ratio (ttm)	N/A
Price to Book (mrq)	0.75
Price to Sales (ttm)	1.47
Price to Cash (ytd)	N/A

Profitability

Gross Margin (ttm)	25.96%
Operating Margin (ttm)	-33.79%
Profit Margin (ttm)	-34.16%
Return on Equity (ttm)	-17.67%
Return on Invested Capital (ttm)	-15.02%
Return on Assets (ttm)	-12.07%

Income Statement

Revenue (ttm)	716.37M
Revenue Per Share (ttm)	1.03
Gross Profit (ttm)	186.11M
EBITDA (ttm)³	-162.75M
Net Income Avi to Common (ttm)	-243.10M
Diluted EPS (ttm)	-0.33

Share Statistics

Beta (5Y Monthly)	1.65
52-Week Change	8.96%
S&P500 52-Week Change	32.45%
S&P500 Member	No
Stock Optionable	Yes
Total Shares Outstanding ¹	697.38M
Dividend Yield	0.00%
Float ⁴	367.80M
% Held by Insiders	47.26%
% Held by Institutions	64.63%

Balance Sheet

Total Cash (mrq)	40.58M
Total Cash Per Share (mrq)	0.06
Total Debt (mrq)	198.24M
Total Debt/Equity (mrq)	14.21%
Current Ratio (mrq)	1.63%
Quick Ratio (mrq)	1.36%
Book Value Per Share (mrq)	2.00

Cash Flow

Operating Cash Flow Per Share (ytd)	-0.09
Free Cash Flow (ytd)	-73.56M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.

¹ Total Shares outstanding is taken from the most recently filed quarterly or annual report.

² Market Cap is calculated using total shares outstanding and the most recent share price.

³ EBITDA is calculated using methodology that may differ from that used by a company in its reporting.

⁴ The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

Opko Health Inc

Trade With A Regulated Broker